A Leader in the $31B* International Cannabis Industry

From Seed to Sale

Cannabis Life Sciences is the developer of a proprietary patent-pending extraction and conversion methodology that has potential to increase both yield and quality of cannabinoid oils extracted from cannabis plants.  CLS is in the process of expanding its business strategy to include cultivation, production, and retail dispensaries, and is currently in the process of acquiring Oasis Cannabis, a Las Vegas based vertically integrated cannabis company.

CLS has executed a definitive agreement to acquire the Oasis Cannabis companies (Alternative Solutions, LLC).  The closing of the transaction is subject to the satisfaction of a number of conditions including our ability to raise cash, and as a result, there can be no assurance that we will be able to close the Oasis Acquisition. See CLS Holdings USA’s filings with the SEC for additional details.

*Industry forecast for sales in 2021 per Forbes

About Us


High Quality, Craft Cannabis

The Oasis warehouse includes 18,000 square feet of dedicated space allocated to cultivation. Our phased approach allows us to expand rapidly and grow with market demand.

Our Cultivation


Proprietary Extraction and Conversion Method

Our proprietary extraction and conversion method allows us to manufacture a broad variety of products: solid and oil concentrates, infused products and edible marijuana products.

Our Production


Key Dispensary Location

We understand the value of location and will make it a point to secure dispensary storefronts in areas that provide direct access to both residents and tourists. The Oasis Cannabis dispensary is located in downtown Las Vegas with easy access from the Strip.

Our Dispensaries

CLS Holdings USA, Inc.

Stock Information

Market Data copyright © 2018 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.